185 related articles for article (PubMed ID: 18980992)
41. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
42. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease.
Erzin Y; Uzun H; Karatas A; Celik AF
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e357-62. PubMed ID: 17725598
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Sarris AH; Kliche KO; Pethambaram P; Preti A; Tucker S; Jackow C; Messina O; Pugh W; Hagemeister FB; McLaughlin P; Rodriguez MA; Romaguera J; Fritsche H; Witzig T; Duvic M; Andreeff M; Cabanillas F
Ann Oncol; 1999 Apr; 10(4):433-40. PubMed ID: 10370786
[TBL] [Abstract][Full Text] [Related]
44. Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes.
Hansen M; Nielsen AR; Vilsbøll T; Lund A; Krarup T; Knop FK; Vestergaard H
Pancreas; 2012 Nov; 41(8):1316-8. PubMed ID: 22647735
[TBL] [Abstract][Full Text] [Related]
45. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
Johansen JS; Bojesen SE; Mylin AK; Frikke-Schmidt R; Price PA; Nordestgaard BG
J Clin Oncol; 2009 Feb; 27(4):572-8. PubMed ID: 19075264
[TBL] [Abstract][Full Text] [Related]
46. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
Kim SH; Das K; Noreen S; Coffman F; Hameed M
World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
[TBL] [Abstract][Full Text] [Related]
47. Serum YKL-40 levels in patients with coronary artery disease.
Kucur M; Isman FK; Karadag B; Vural VA; Tavsanoglu S
Coron Artery Dis; 2007 Aug; 18(5):391-6. PubMed ID: 17627189
[TBL] [Abstract][Full Text] [Related]
48. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
Dehn H; Høgdall EV; Johansen JS; Jørgensen M; Price PA; Engelholm SA; Høgdall CK
Acta Obstet Gynecol Scand; 2003 Mar; 82(3):287-93. PubMed ID: 12694127
[TBL] [Abstract][Full Text] [Related]
49. Plasma YKL-40, a new biomarker for atrial fibrillation?
Henningsen KM; Therkelsen SK; Johansen JS; Bruunsgaard H; Svendsen JH
Europace; 2009 Aug; 11(8):1032-6. PubMed ID: 19411674
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
Schultz NA; Christensen IJ; Werner J; Giese N; Jensen BV; Larsen O; Bjerregaard JK; Pfeiffer P; Calatayud D; Nielsen SE; Yilmaz MK; Holländer NH; Wøjdemann M; Bojesen SE; Nielsen KR; Johansen JS
PLoS One; 2013; 8(6):e67059. PubMed ID: 23840582
[TBL] [Abstract][Full Text] [Related]
51. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
[TBL] [Abstract][Full Text] [Related]
52. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
[TBL] [Abstract][Full Text] [Related]
53. High serum YKL-40 level in patients with small cell lung cancer is related to early death.
Johansen JS; Drivsholm L; Price PA; Christensen IJ
Lung Cancer; 2004 Dec; 46(3):333-40. PubMed ID: 15541818
[TBL] [Abstract][Full Text] [Related]
54. Plasma YKL-40 levels in healthy subjects from the general population.
Bojesen SE; Johansen JS; Nordestgaard BG
Clin Chim Acta; 2011 Apr; 412(9-10):709-12. PubMed ID: 21272568
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.
Brasso K; Christensen IJ; Johansen JS; Teisner B; Garnero P; Price PA; Iversen P
Prostate; 2006 Apr; 66(5):503-13. PubMed ID: 16372331
[TBL] [Abstract][Full Text] [Related]
56. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.
Johansen JS; Cintin C; Jørgensen M; Kamby C; Price PA
Eur J Cancer; 1995; 31A(9):1437-42. PubMed ID: 7577068
[TBL] [Abstract][Full Text] [Related]
57. High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer.
Choi IK; Kim YH; Kim JS; Seo JH
Acta Oncol; 2010 Aug; 49(6):861-4. PubMed ID: 20553098
[No Abstract] [Full Text] [Related]
58. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
[TBL] [Abstract][Full Text] [Related]
59. YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.
Corradi M; Goldoni M; Alinovi R; Tiseo M; Ampollini L; Bonini S; Carbognani P; Casalini A; Mutti A
Anticancer Res; 2013 Dec; 33(12):5517-24. PubMed ID: 24324091
[TBL] [Abstract][Full Text] [Related]
60. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
